Market revenue in 2022 | USD 289.6 million |
Market revenue in 2030 | USD 510.3 million |
Growth rate | 7.3% (CAGR from 2022 to 2030) |
Largest segment | Gelatin-based/animal-based |
Fastest growing segment | Non-Animal-Based |
Historical data | 2018 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Gelatin-Based/Animal-Based, Non-Animal-Based |
Key market players worldwide | Thermo Fisher Scientific Inc, EyePoint Pharmaceuticals Inc, Catalent Inc, Kuehne + Nagel International AG, Lonza Group Ltd, Procaps Group SA, Soft Gel Technologies, EuroCaps, Captek Softgel International, Sirio Pharma, Fuji Capsule |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to softgel capsules market will help companies and investors design strategic landscapes.
Gelatin-based/animal-based was the largest segment with a revenue share of 68.96% in 2022. Horizon Databook has segmented the Germany softgel capsules market based on gelatin-based/animal-based, non-animal-based covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of country-level data and insights on the Germany softgel capsules market , including forecasts for subscribers. This country databook contains high-level insights into Germany softgel capsules market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account